237 related articles for article (PubMed ID: 24829201)
21. Notch signaling promotes disease initiation and progression in murine chronic lymphocytic leukemia.
Tardivon D; Antoszewski M; Zangger N; Nkosi M; Sordet-Dessimoz J; Hendriks R; Koch U; Radtke F
Blood; 2021 Jun; 137(22):3079-3092. PubMed ID: 33512383
[TBL] [Abstract][Full Text] [Related]
22. A Novel Assay for the Identification of NOTCH1 PEST Domain Mutations in Chronic Lymphocytic Leukemia.
Campregher PV; Petroni RC; Muto NH; Sitnik R; de Carvalho FP; Bacal NS; Velloso ED; Oliveira GB; Pinho JR; Torres DC; Mansur MB; Hassan R; Lorand-Metze IG; Chiattone CS; Hamerschlak N; Mangueira CL
Biomed Res Int; 2016; 2016():4247908. PubMed ID: 28074183
[No Abstract] [Full Text] [Related]
23. 11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.
Dickinson JD; Gilmore J; Iqbal J; Sanger W; Lynch JC; Chan J; Bierman PJ; Joshi SS
Leuk Lymphoma; 2006 Feb; 47(2):231-44. PubMed ID: 16321852
[TBL] [Abstract][Full Text] [Related]
24. Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL.
Kriston C; Bödör C; Szenthe K; Bánáti F; Bánkuti B; Csernus B; Reiniger L; Csomor J; Matolcsy A; Barna G
Hematol Oncol; 2017 Mar; 35(1):58-63. PubMed ID: 26119874
[TBL] [Abstract][Full Text] [Related]
25. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion.
Sembries S; Pahl H; Stilgenbauer S; Döhner H; Schriever F
Blood; 1999 Jan; 93(2):624-31. PubMed ID: 9885225
[TBL] [Abstract][Full Text] [Related]
27. Regulation and function of adhesion molecules in B-cell chronic lymphocytic leukaemia.
Jewell AP; Yong KL
Acta Haematol; 1997; 97(1-2):67-72. PubMed ID: 8999721
[TBL] [Abstract][Full Text] [Related]
28. Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R
Haematologica; 2012 Jun; 97(6):952-60. PubMed ID: 22207686
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
30. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
[TBL] [Abstract][Full Text] [Related]
31.
Close V; Close W; Kugler SJ; Reichenzeller M; Yosifov DY; Bloehdorn J; Pan L; Tausch E; Westhoff MA; Döhner H; Stilgenbauer S; Oswald F; Mertens D
Blood; 2019 Feb; 133(8):830-839. PubMed ID: 30510140
[No Abstract] [Full Text] [Related]
32. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
Jelloul FZ; Yang R; Garces S; Kanagal-Shamanna R; Ok CY; Loghavi S; Routbort MJ; Zuo Z; Yin CC; Floyd K; Bassett RL; Wierda W; Jain N; Thompson P; Luthra R; Medeiros LJ; Patel KP
Leuk Res; 2022 May; 116():106827. PubMed ID: 35430388
[TBL] [Abstract][Full Text] [Related]
33. Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL.
Decker S; Zirlik K; Djebatchie L; Hartmann D; Ihorst G; Schmitt-Graeff A; Herchenbach D; Jumaa H; Warmuth M; Veelken H; Dierks C
Blood; 2012 Jan; 119(4):997-1007. PubMed ID: 22130798
[TBL] [Abstract][Full Text] [Related]
34. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
Baldoni S; Del Papa B; Dorillo E; Aureli P; De Falco F; Rompietti C; Sorcini D; Varasano E; Cecchini D; Zei T; Di Tommaso A; Rosati E; Alexe G; Roti G; Stegmaier K; Di Ianni M; Falzetti F; Sportoletti P
Int J Cancer; 2018 Aug; 143(4):958-970. PubMed ID: 29508386
[TBL] [Abstract][Full Text] [Related]
35. Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12.
Porpaczy E; Bilban M; Heinze G; Gruber M; Vanura K; Schwarzinger I; Stilgenbauer S; Streubel B; Fonatsch C; Jaeger U
Eur J Clin Invest; 2009 Jul; 39(7):568-75. PubMed ID: 19453646
[TBL] [Abstract][Full Text] [Related]
36. The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.
Oscier DG; Rose-Zerilli MJ; Winkelmann N; Gonzalez de Castro D; Gomez B; Forster J; Parker H; Parker A; Gardiner A; Collins A; Else M; Cross NC; Catovsky D; Strefford JC
Blood; 2013 Jan; 121(3):468-75. PubMed ID: 23086750
[TBL] [Abstract][Full Text] [Related]
37. Obinutuzumab-induced coagulopathy in chronic lymphocytic leukaemia with trisomy 12.
Walter HS; Jayne S; Mensah P; Miall FM; Lyttelton M; Dyer MJ
Blood Cancer J; 2016 Jun; 6(6):e435. PubMed ID: 27315112
[No Abstract] [Full Text] [Related]
38. Common nonmutational
Fabbri G; Holmes AB; Viganotti M; Scuoppo C; Belver L; Herranz D; Yan XJ; Kieso Y; Rossi D; Gaidano G; Chiorazzi N; Ferrando AA; Dalla-Favera R
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2911-E2919. PubMed ID: 28314854
[TBL] [Abstract][Full Text] [Related]
39. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.
Villamor N; Conde L; Martínez-Trillos A; Cazorla M; Navarro A; Beà S; López C; Colomer D; Pinyol M; Aymerich M; Rozman M; Abrisqueta P; Baumann T; Delgado J; Giné E; González-Díaz M; Hernández JM; Colado E; Payer AR; Rayon C; Navarro B; José Terol M; Bosch F; Quesada V; Puente XS; López-Otín C; Jares P; Pereira A; Campo E; López-Guillermo A
Leukemia; 2013 Apr; 27(5):1100-6. PubMed ID: 23295735
[TBL] [Abstract][Full Text] [Related]
40. Adhesion molecules expression in CLL: Potential impact on clinical and hematological parameters.
Kamel AM; El-Sharkawy NM; Osman RA; Abd El-Fattah EK; El-Noshokaty E; Abd El-Hamid T; Kandeel EZ
J Egypt Natl Canc Inst; 2016 Mar; 28(1):31-7. PubMed ID: 26873628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
